About
Datum Orthobiologics was founded to provide innovative orthopedic ossification, bone formation, and tissue regeneration solutions. The company develops advanced biomaterials designed to improve the long-term healing and regeneration of musculoskeletal components. The ossification properties of Datums GLYMATRIX-based products make them ideal prospects for spinal fusion and fracture grafts in trauma medicine. Datum Orthobiologics is focusing its initial efforts on bone graft products. Products featuring Datum Biotechs patented GLYMATRIX technology have been used safely and effectively in over half a million dental and aesthetic procedures, with more than 110 scientific publications and numerous case studies.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of Datum Orthobiologics?
- Datum Orthobiologics focuses on developing innovative orthopedic ossification, bone formation, and tissue regeneration solutions, specifically advanced biomaterials for musculoskeletal healing.
- When was Datum Orthobiologics founded?
- Datum Orthobiologics was founded in May 2014.
- What is the status of Datum Orthobiologics as of February 2019?
- As of February 2019, Datum Orthobiologics is inactive and ceased to operate.
- What technology does Datum Orthobiologics utilize in its products?
- Datum Orthobiologics utilizes the patented GLYMATRIX technology in its products.
- In which medical fields has GLYMATRIX technology been previously applied?
- Products featuring GLYMATRIX technology have been used in over half a million dental and aesthetic procedures.
- What is the initial product focus for Datum Orthobiologics?
- Datum Orthobiologics is focusing its initial efforts on bone graft products.
- Where is Datum Orthobiologics headquartered?
- Datum Orthobiologics is headquartered in Har Adar, Israel.
- Who is a co-founder of Datum Orthobiologics?
- Itay Itzhaky is a co-founder of Datum Orthobiologics.